Neuropsychological and Behavioral Testing in Younger Patients With Cancer
- Conditions
- Childhood Malignant Neoplasm
- Registration Number
- NCT00772200
- Lead Sponsor
- Children's Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> - The patient must be currently be enrolled or plan to be enrolled on a COG<br> therapeutic study that aims to examine neuropsychological, social, emotional, and/or<br> behavioral functioning<br><br> - The patient must have receptive and expressive language skills in English, French,<br> or Spanish; if a patient meets these criteria but the parent/guardian speaks a<br> language other than English, French, or Spanish, the patient may still be enrolled<br> and tested, and the parent-report measures should be omitted<br><br> - All patients and/or their parents or legal guardians must sign a written informed<br> consent<br><br> - All institutional, Food and Drug Administration (FDA), and National Cancer Institute<br> (NCI) requirements for human studies must be met<br><br>Exclusion Criteria:<br><br> - Patients with a history of moderate to profound intellectual disability (i.e.<br> intelligence quotient [IQ] =< 55) are not eligible for enrollment; PLEASE NOTE:<br> Children with a prior history of attention deficit hyperactivity disorder (ADHD) or<br> a specific learning disability (e.g., dyslexia) are eligible for this study
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compliance rate for completion of neuropsychological and behavioral battery
- Secondary Outcome Measures
Name Time Method